CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Alcami Corporation

Jorge Rodriguez, Head of Marketing

Leadership at the Intersection of Science, Strategy and Storytelling

Jorge Rodriguez

Jorge Rodriguez

Marketing Insight Voice

Jorge Rodriguez brings a rare blend of scientific depth and strategic vision to his role as Head of Marketing at Alcami Corporation. His career began in biomedical engineering, where he gained a strong appreciation for the science behind therapeutic innovation.


Early on, he saw the importance of translating complex scientific work into clear strategies that move breakthrough medicines toward the patients who need them. That insight led him to pursue an MBA, expanding his commercial perspective and strengthening his understanding of the global pharma and biotech landscape. Today, he draws on both disciplines to guide Alcami’s marketing efforts, shaping narratives that connect scientific rigor with real-world impact.


Through this article, Rodriguez shares his professional evolution through the CDMO industry and the passion for data-driven storytelling in pharma marketing and his excitement about the future of predictive, personalized engagement.


How I Found My Path in the CDMO World


My transition into contract development and manufacturing organization (CDMO) space was a natural evolution.


I was drawn to its complexity and its pivotal role in enabling innovation, from early-stage development to commercial-scale manufacturing.


Through leadership roles at Catalent, WuXi Advanced Therapies and now Alcami, I’ve had the privilege of contributing to the growth of advanced therapies, sterile fill/finish and oral solid dose platforms. The CDMO model uniquely blends technical depth, strategic agility and client partnership—an environment that aligns perfectly with my strengths and aspirations.


A defining moment, for me, was spearheading digital commerce and business intelligence at WuXi’s Advanced Therapies Unit. Reporting directly to the Commercial Head, I was tasked with aligning cross-functional teams—marketing, sales, operations and R&D—around a unified growth strategy. This experience reinforced the importance of intellectual flexibility, empathetic leadership and datadriven decision-making.


At Catalent, I progressed through roles in marketing automation, CRM systems and sales enablement, gaining a holistic view of commercial operations. Reporting to both the chief marketing officer and the VP of sales force effectiveness gave me a dual lens into strategic marketing and sales support.


I was entrusted with managing co-op rotational talent, a systems analyst and a team of 10–15 inside sales representatives—an opportunity that allowed me to master lead nurturing, qualification processes and team leadership.


My current task is to report to the Chief Strategy Officer at Alcami, which gives me broad ownership across all facets of marketing: business intelligence, public relations, events and tradeshows, digital marketing, customer experience, site and HR support, sales enablement, product marketing and internal/external communications.


This role not only empowers execution but provides strategic headroom to think holistically, craft growth strategies and develop the mindset of a future C-suite leader.


Lead with empathy and agility. Whether guiding a team or shaping strategy, understanding people and adapting to change will define your impact as CDMO.


The Experience That Changed How I Approach Problems


One of the most challenging yet rewarding experiences was leading digital transformation initiatives across multiple CDMO platforms. Integrating systems like Salesforce, Eloqua and HubSpot across global teams required not only technical fluency but also deep stakeholder alignment and change management.


In a past role, scaling digital sales operations while maintaining regulatory compliance and scientific integrity presented a unique challenge.


These experiences taught me that resilience is rooted in clarity of purpose and that effective problem-solving is both collaborative and iterative. I’ve learned to approach challenges with a systems mindset— balancing short-term execution with long-term strategic impact.


Where My Love for Storytelling Meets the Power of Analytics


In pharma manufacturing, storytelling must be anchored in data.


I leverage tools like marketing automation, lead scoring and personabased segmentation to uncover client needs and behavioral patterns. These insights inform narratives that connect technical capabilities—such as sterile fill/finish or analytical testing—to real-world outcomes for patients and partners.


What excites me most is the shift toward personalized engagement and predictive analytics. Marketing is evolving from a promotional function to a strategic growth engine—one that orchestrates meaningful conversations across the buyer’s journey. The integration of AI, automation and omnichannel strategies is redefining how we build trust, deliver value and scale impact in the CDMO space.


Three Lessons I Pass On


First, embrace complexity. The CDMO ecosystem is multifaceted and success requires comfort with ambiguity and the ability to navigate scientific, regulatory and commercial domains simultaneously.


Second, stay curious and collaborative. Innovation thrives at the intersections—between disciplines, departments and organizations. Building strong networks and fostering open dialogue is essential.


Finally, lead with empathy and agility. Whether guiding a team or shaping strategy, understanding people and adapting to change will define your impact. The future of CDMO leadership lies in integrating science with strategy and doing so with a human-centered, forward-looking approach.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.

Editorial Lens

Customer-centric growth strategies are increasingly defined by how effectively organizations translate audience understanding into sustained engagement across fragmented digital ecosystems. This perspective underlines how modern marketing leadership depends on aligning customer insight with scalable execution models that strengthen long-term brand relevance.

The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/leadership-perspective/jorge-rodriguez-nwid-3660.html